Clinical Trial Update: Pentaerithrityl Tetranitrate (PETN) for Secondary Prevention of Intrauterine Growth Restriction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for PETN as secondary prevention of intrauterine growth restriction, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Retardation
• Intrauterine Growth Retardation
• Pregnancy-related Conditions

Drugs mentioned

• Pentaerithrityl tetranitrate (pentaerithrityl tetranitrate)

Snippet

Sponsor: Jena University Hospital | Conditions: Fetal Growth Retardation, Pregnancy Related | Phase 3 | Status: UNKNOWN